[USA] In a coup for Wayne State University’s reputation as a research center, a small eye-care company RetroSense Therapeutics, that uses green algae genes to treat a type of human blindness has sold for $60 million.
Treatment Bird view: The company’s treatment uses a virus to deliver a #photoreceptor #gene from the #algae into a human patient’s eye. The research, which aims to cure an inherited disease that causes people to slowly go blind, has shown promise. The #Federal #Drug #Administration gave permission for a clinical trial.
This Company, which is now based at the Ann Arbor SPARK business accelerator, was acquired this month by Allergan, a $4 billion-a-year maker of skin and eye care products.
Research Contribution:
#Dr. Zhuo-Hua Pan of Wayne State University’s Medical School helped develop a novel treatment for a type of vision loss.
Using Pan’s discoveries, RetroSense is developing a treatment for #retinitis #pigmentosa, an inherited condition in which light receptor cells in the retina die, leading to gradual blindness or partial vision loss. The problem affects about 100,000 people in the U.S., and there have been no effective treatments.
Result Impact:
Dr. Pan’s novel research involved using a virus that delivers a #photoreceptor gene from #green #algae. Pan discovered that the gene could ultimately lead to the brain perceiving light again.
Dr. Pan’s novel research involved using a virus that delivers a #photoreceptor gene from #green #algae. Pan discovered that the gene could ultimately lead to the brain perceiving light again.
Visit Our facebook group Spirulina Entrepreneurs group for recent Scientific Updates on #Algae #Research and #Industry
No comments:
Post a Comment